Medical procedures, such as computed tomography (CT), chest x-rays, radiation therapy, and positron emission tomography (PET) scans, can cause cell damage that results in cancer. Exposure to radiation emitted through these medical systems can also cause nausea, hair loss, skin and mouth sores, fainting, bleeding, vomiting, and confusion and diarrhea among the exposed patients. The radiation exposure is, however, not only limited to patients, but can also harm medical practitioners..
Thus, the increasing exposure of patients to radiation, owing to the rising prevalence of chronic diseases, will drive the radiation dose management (RDM) market at an exceptional CAGR of 46% during the forecast period (2017–2023). According to P&S Intelligence, the market revenue will surge from $129.8 million in 2016 to $1.7 billion by 2023. The World Health Organization (WHO) states that around 17.9 million fatalities were caused due to cardiovascular diseases (CVDs) in 2019, accounting for approximately 32% of all global deaths.
The product and services segment of the radiation dose management (RDM) market is divided into solutions and services. Under this segment, the solutions category generated the higher revenue in 2016, as RDM solutions allow healthcare providers to track and evaluate the radiations emitted from several modalities. This category is further bifurcated into integrated solutions and standalone solutions. Of these, the integrated solutions category will witness the faster growth in the forecast years because of their higher efficiency, owing to the easy integration of such solutions with electronic health record (EHR) solutions and picture archiving and communication systems (PACS).
Whereas, the European radiation dose management market is expected to demonstrate the fastest growth during the forecast years, owing to the rising cases of chronic ailments and growing public awareness about radiation dose safety through conferences and campaigns. The European Union (EU) states that CVDs caused around 1.68 million deaths in EU countries in 2016. Further, Fondation de France estimates that approximately 12,000 heart attacks are recorded in France every year. Additionally, the International Agency for Research on Cancer (IARC) reveals that 628,519 people in Germany were diagnosed with cancer in 2020.
Browse Full Report Radiation Dose Management Market Competitive Benchmarking
This study covers
- Major factors driving the market and their impact during the short, medium, and long terms
- Market restraints and their impact during the short, medium, and long terms
- Recent trends and evolving opportunities for the market participants
- Historical and the present size of the market segments and understand their comparative future potential
- Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
- Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
- Major players operating in the market and their service offerings
